The human ABO blood group is determined by the ABO gene located on chromosome 9. This gene contains 7 exons, of which the last 2 (6 and 7) comprise nearly 80% of the coding sequence of the gene and encode the catalytic do-main [1, 2] . The genetic underpinnings of several B subtype phenotypes have been reported [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Although it is considerably rarely observed in Korea and probably the entire Asia, the B3 phenotype is the most common B subtype phenotype [6, 7] . B 3 alleles are heterogeneous and contain single nucleotide polymorphisms (SNPs) scattered throughout both the coding and intronic DNA sequences; however, some individuals with the B3 phenotype had no unexpected SNPs relative to the B101 allele [8] .
INTRODUCTION the B305 allele. Although the B305 allele was first reported in 2 Chinese individuals, it has not yet been reported in the Koreans, and the impact of the M142T mutation in exon 7 of the ABO gene on the activity of B transferase has also not been studied. To confirm that the B305 allele was responsible for the weak B phenotype in the mother, we transfected HeLa cells with a recombinant B305 allele and studied its expression characteristics using flow cytometry. We then compared the expression of the B305 transfects to that of the HeLa cells transfected with a normal B101 allele and another representative B subtype allele, Bx01 (871G>A, D291N).
CASE REPORT
Five blood samples from the family of a 7-day-old female neonate were sent to our laboratory for the resolution of an ABO discrepancy between the neonate and her parents.
Written informed consent for the genotyping was obtained from all family members and from the parents on behalf of the neonate. Forward typing was performed by the manual tube method using murine monoclonal anti-A, anti-B, anti-H, and anti-AB antisera (Biotest AG, Dreieich, Germany) according to standard protocols [13] . Reverse typing was also performed by the tube method using A1 and B RBCs (Diamed, Cressier sur Morat, Switzerland) [13] .
The serological findings are presented in Fig. 1 . The neo-nate' s plasma did not react with A1 or B reagent red cells.
Adsorption and elution tests could not be performed on
her RBCs due to the small sample volume. The RBCs from both the neonate' s mother (II-3) and aunt (II-1) demonstrated 1+ mixed-field agglutination with anti-B reagents (B3 phenotype), and anti-B was not detected in either of their reverse typings.
The coding and flanking intronic sequences of ABO exons 6 and 7 of the neonate and 4 other family members were amplified, cloned, sequenced, and analyzed, as described previously [6, [14] [15] [16] . The B305 allele (425T>C, M142T) was detected in the neonate, her mother, and her aunt. The II   III   2   2 3 1 antigen produced by the control B101 transfects (Fig. 3C ). Expression studies can be a useful tool for studying the phenotype produced by the A and B subtype alleles [17, 18] . In this study, to better understand the effects of the M142T mutation on the activity of B glycosyltransferase,
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DISCUSSION
we created an expression model using HeLa cells transfected with B305 cDNA. The MFIs of the B305 and Bx01 subtype transfects were lesser than those of the B101 transfects, and the MFIs of the former transfects were reasonably consistent with those of the reported RBC serological findings, although a mixed-field pattern was not observed with the B305 transfect probably because of the differences in the antibodies used for pretransfusion testing and those used for flow cytometry experiments.
In summary, by conducting flow cytometric analysis of HeLa cells transfected with a recombinant B305 allele, we confirmed that the M142T (425 T>C) mutation reduces the B-enzyme' s activity and leads to a B subtype phenotype that is detectable in pretransfusion testing.
